legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

# Andelyn Biosciences Selected for Manufacturing AAV Therapies

## COLUMBUS, Ohio, May 23, 2024 /PRNewswire/ — Andelyn Biosciences, Inc., a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been chosen to manufacture adeno-associated vectors (AAV) therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC).

The partnership with CIRM aims to develop customized gene therapies for rare diseases. Andelyn’s role includes optimizing and scaling AAV therapy processes for Congenital Hereditary Endothelial Dystrophy – Type 1.

## How AI legalese decoder Can Help

The AI legalese decoder can assist in simplifying complex legal language, ensuring that agreements and contracts are easily understandable to all parties involved. This can help in speeding up the process of reviewing and finalizing legal documents, ultimately leading to more efficient and effective collaborations.

## Quote from Andelyn’s Chief Commercial Officer

Matt Niloff, Chief Commercial Officer of Andelyn, highlighted the company’s expertise in AAV gene therapies and its alignment with the CIRM/BGTC’s mission. By leveraging the AAV Curator™ Platform, Andelyn aims to overcome obstacles in gene therapy development.

## Perspective from CIRM’s Vice President

Dr. Abla Creasey, Vice President of Therapeutics Development at CIRM, emphasized the importance of the partnership with Andelyn in advancing treatments for rare diseases like Congenital Hereditary Endothelial Dystrophy.

## About Andelyn Biosciences, Inc.

Andelyn Biosciences is a cell and gene therapy CDMO that specializes in the production of viral vectors for gene therapy. With extensive experience and state-of-the-art facilities in Columbus, Ohio, Andelyn supports the development and manufacturing of life-altering gene therapies for rare and prevalent diseases.

The AI legalese decoder can help in simplifying legal language used in contracts and agreements, making the content more accessible to all parties involved. By breaking down complex legal terms and phrases, the decoder ensures clarity and transparency in legal documents, ultimately facilitating smoother collaborations and agreements.

## Conclusion

Through its partnership with CIRM/BGTC and the utilization of its advanced technology platforms, Andelyn Biosciences is at the forefront of developing innovative gene therapies for rare diseases. The company’s commitment to excellence and quality in manufacturing processes positions it as a key player in the field of cell and gene therapy.

For more information on Andelyn Biosciences, visit their website at andelynbio.com.

## About the California Institute for Regenerative Medicine (CIRM)

CIRM is dedicated to accelerating stem cell treatments to patients with unmet medical needs. With a focus on developing promising stem cell technologies, CIRM plays a pivotal role in advancing the future of cellular medicine.

For more information about CIRM, visit www.cirm.ca.gov.

*SOURCE Andelyn Biosciences*

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link